FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
0001457612falseNasdaq00014576122022-05-202022-05-20UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington...
0001457612false--12-312022Q100014576122022-01-012022-03-3100014576122022-04-29xbrli:shares00014576122022-03-31is...
Leerink Partners analyst Daina Graybosch maintained a Buy rating on Genocea Biosciences (GNCA – Research Report) on April 27 and set a price...
00014576122021FYFALSE58,783,50300014576122021-01-012021-12-3100014576122021-06-30iso4217:USD00014576122022-04-25...
H.C. Wainwright analyst Joseph Pantginis downgraded Genocea Biosciences (GNCA – Research Report) to Hold today. The company's shares closed last...
0001457612falseNasdaq00014576122022-04-282022-04-28UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington...
Leerink Partners analyst Daina Graybosch maintained a Buy rating on Genocea Biosciences (GNCA – Research Report) yesterday. The company's shares...
Needham analyst Gil Blum reiterated a Buy rating on Genocea Biosciences (GNCA – Research Report) today and set a price target of $6.00. The...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.